Motilium is an oral domperidone product for reducing nausea and vomiting. How much to use and how often depends on the purpose of use and is agreed with a doctor or pharmacist.
Motilium is an oral domperidone product for reducing nausea and vomiting. How much to use and how often depends on the purpose of use and is agreed with a doctor or pharmacist.
Motilium contains domperidone per tablet. Domperidone is classified as an antiemetic and peripheral dopamine receptor antagonist, meaning that it acts mainly on the digestive system and the vomiting centre pathways outside the brain.
Dopamine can slow stomach movement and trigger nausea in susceptible people. Domperidone blocks dopamine D2 receptors in the upper gastrointestinal tract, supporting more coordinated gastric emptying and reducing the urge to vomit.
How much to use and how often depends on the purpose of use and is agreed with a doctor or pharmacist.
Motilium contains domperidone per tablet. Domperidone is classified as an antiemetic and peripheral dopamine receptor antagonist, meaning that it acts mainly on the digestive system and the vomiting centre pathways outside the brain.
Dopamine can slow stomach movement and trigger nausea in susceptible people. Domperidone blocks dopamine D2 receptors in the upper gastrointestinal tract, supporting more coordinated gastric emptying and reducing the urge to vomit.
Motilium is used for nausea and vomiting rather than for long-term management of indigestion, reflux, bloating, or chronic stomach pain. The HPRA product information limits use to the lowest suitable dose for the shortest suitable duration. [1]
How much to use and how often depends on the purpose of use and should be agreed with a doctor or pharmacist.
Motilium is intended to reduce nausea and vomiting. It can be useful when nausea occurs with delayed gastric emptying, migraine, short-lived stomach illness, or as a treatment-related symptom where domperidone is clinically appropriate.
The benefit is usually symptom control, not removal of the underlying cause. A person with vomiting from gastroenteritis may feel relief while the infection resolves naturally. Someone with recurrent vomiting, severe pain, fever, blood in vomit, black stools, or dehydration needs medical assessment rather than repeated short courses.
How much to use and how often depends on the purpose of use and is agreed with a doctor or pharmacist.
How much to use and how often depends on the purpose of use and is agreed with a doctor or pharmacist.
A frequent mistake is taking domperidone only after eating because nausea has already started. Absorption is delayed after food, so pre-meal timing gives the medicine a better chance to work when it is needed.
Motilium is not for you if you have a known allergy to domperidone or any tablet ingredient. It is also unsuitable where speeding stomach movement could be harmful, such as a suspected gastrointestinal blockage, perforation, or bleeding.
Do not use Motilium if you have:
Some medicines raise domperidone levels or add to QT prolongation. This includes several antifungal medicines, macrolide antibiotics such as clarithromycin or erythromycin, certain HIV treatments, and medicines used for arrhythmias or psychiatric conditions. The interaction risk comes from combined effects on cardiac electrical activity or liver enzymes, not from nausea itself.
Older adults deserve extra caution because cardiac risk rises with age and coexisting conditions. A history of heart disease, kidney problems causing electrolyte disturbance, or use of diuretics should be raised before treatment is started.
Most people taking a short course tolerate Motilium without major difficulty. Dry mouth is among the more familiar effects. Headache, sleepiness, diarrhoea, anxiety, rash, or abdominal cramps can also occur.
Domperidone may increase prolactin, a hormone involved in milk production. With repeated use, this can rarely lead to breast tenderness, unexpected milk secretion, menstrual changes, or breast enlargement in men. These symptoms merit prompt clinical review.
The safety issue that shapes domperidone prescribing is heart rhythm risk. Domperidone can prolong the QT interval, an electrical measurement on an ECG, and this may predispose susceptible people to serious arrhythmias. The European Medicines Agency review identified higher concern with doses above 30 mg daily, older age, heart disease, and medicines that affect heart rhythm or domperidone metabolism. [3]
Seek urgent medical care for fainting, a racing or irregular heartbeat, severe dizziness, chest discomfort, or collapse. These are not effects to watch at home.
Domperidone works through two linked actions:
Another common issue is using domperidone for bloating alone. It may aid upper gastrointestinal motility in selected situations, yet bloating without nausea and vomiting needs a different clinical assessment, especially if it persists or changes suddenly.
Motilium and a generic domperidone tablet of the same strength use domperidone as the active substance. A generic medicine authorised through the European system must demonstrate comparable exposure to the active ingredient through bioequivalence testing, which assesses how quickly and how much drug reaches the bloodstream. [2]
| Feature | Motilium tablets | Generic domperidone tablets |
|---|---|---|
| Active substance | Domperidone | Domperidone |
| Strength discussed here | 10 mg per tablet | 10 mg per tablet |
| Therapeutic class | Antiemetic; peripheral dopamine antagonist | Antiemetic; peripheral dopamine antagonist |
Excipients, tablet appearance, and coating can differ between products. Those details matter for people with a known intolerance to a specific ingredient, yet the clinical purpose comes from domperidone itself.
A generic alternative does not change the key safety limits for domperidone. The same restrictions around daily dose, duration, heart rhythm risk, and interacting medicines still apply.
In clinical practice, clinicians tend to reserve Motilium for defined episodes of nausea and vomiting rather than recurring, unexplained digestive discomfort. The aim is a short course at the lowest working dose, with attention to medicines that may alter cardiac rhythm.
Doctors also look beyond nausea itself. Recurrent vomiting may reflect migraine, infection, medication effects, pregnancy, bowel obstruction, gallbladder disease, metabolic illness, or another cause requiring different treatment. Motilium can reduce the symptom, but it does not diagnose the cause.
A useful expectation is practical: relief may begin after a dose when the medicine is taken before food, yet persistent vomiting should not be managed by increasing the dose. More domperidone does not mean better control and can increase avoidable cardiac risk.
Pregnancy requires an individual medical decision because nausea has many possible causes and treatment choice depends on severity, timing, and medical history. The HPRA product information advises that domperidone should be used in pregnancy only when the expected benefit justifies its use. Domperidone passes into breast milk in small amounts, and breastfeeding use also needs clinician-led assessment because infant exposure and maternal cardiac risk must be considered. This information reflects the HPRA’s 2024 product documentation.
Domperidone is usually taken 15 to 30 minutes before a meal because food can delay absorption. Some people notice reduced nausea after the first dose, while others need several correctly timed doses across a short illness before they feel a clear difference. The EMA’s 2014 review supports short-term domperidone use while the underlying trigger is assessed. Ongoing vomiting despite treatment needs reassessment.
Motilium does not usually require tapering after a short course. It can generally be stopped when nausea and vomiting settle, provided it was being used as prescribed for a short-term problem. The EMA’s 2014 restrictions support short-duration use, which reduces unnecessary exposure. If symptoms return straight away, the next step is to investigate the cause rather than restarting or increasing doses without review.
Motilium is taken before food, ideally 15 to 30 minutes before a meal. Taking it after eating can delay its effect because the stomach is already processing food. The HPRA product information published in 2024 gives pre-meal administration for oral domperidone tablets. A small amount of water is sufficient.
Motilium tablets are intended for adults and adolescents aged 12 years and older who weigh at least 35 kg. It should not be used in younger children or in anyone below that weight threshold. The EMA’s 2014 review restricted domperidone use in children because the benefit-risk balance is less favourable outside the defined age and weight group. Childhood vomiting also needs careful assessment for dehydration and infection.
Yes. A known prolonged QT interval, a previous serious arrhythmia, heart failure, marked bradycardia, or a medicine that prolongs QT can rule out domperidone use. The EMA’s 2014 safety review linked domperidone with a small increased risk of serious cardiac effects in susceptible groups. Tell the prescriber about fainting episodes, palpitations, heart disease, and every medicine you take before using Motilium.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Based on 5 reviews
I took one tablet before breakfast and dinner for three days after a stomach bug. The nausea eased on the first day, and I was able to keep fluids down again. I stopped once I felt normal rather than continuing the tablets.
Three days 1 Nov 2026My doctor prescribed 10 mg before meals after a short spell of vomiting. I made the mistake of taking the first tablet after lunch, and it seemed slow. Taking it before food the next day worked better, although my mouth felt dry.
7 Nov 2026I used Motilium for four days while a migraine was making me sick. It helped enough that I could take my usual migraine treatment and drink water. I did not need it after the migraine settled.
Four days 11 Oct 2026I stopped after two doses because I felt light-headed and noticed a fluttering feeling in my chest. It may not have been caused by the tablets, but I did not take another dose and arranged a medical review. My other medicines needed checking.
Two doses 21 Oct 2026I used it for nausea after a viral illness and took one tablet before meals for two days. The vomiting settled, but the tablet did not do much for the tiredness or loose stools, which took longer to pass.
Two days 14 Oct 2026
